Combination of miRNA499 and miRNA133 Exerts a Synergic Effect on Cardiac Differentiation

Several studies have demonstrated that miRNA are involved in cardiac development, stem cell maintenance, and differentiation. In particular, it has been shown that miRNA133, miRNA1, and miRNA499 are involved in progenitor cell differentiation into cardiomyocytes. However, it is unknown whether different miRNA may act synergistically to improve cardiac differentiation. We used mouse P19 cells as a cardiogenic differentiation model. miRNA499, miRNA1, or miRNA133 were transiently over‐expressed in P19 cells individually or in different combinations. The over‐expression of miRNA499 alone increased the number of beating cells and the association of miRNA499 with miRNA133 exerted a synergistic effect, further increasing the number of beating cells. Real‐time polymerase chain reaction showed that the combination of miRNA499 + 133 enhanced the expression of cardiac genes compared with controls. Western blot and immunocytochemistry for connexin43 and cardiac troponin T confirmed these findings. Importantly, caffeine responsiveness, a clear functional parameter of cardiac differentiation, was increased by miRNA499 in association with miRNA133 and was directly correlated with the activation of the cardiac troponin I isoform promoter. Cyclic contractions were reversibly abolished by extracellular calcium depletion, nifedipine, ryanodine, and IP3R blockade. Finally, we demonstrated that the use of miRNA499 + 133 induced cardiac differentiation even in the absence of dimethyl sulfoxide. Our results show that the areas spontaneously contracting possess electrophysiological and pharmacological characteristics compatible with true cardiac excitation‐contraction coupling. The translational relevance of our findings was reinforced by the demonstration that the over‐expression of miRNA499 and miRNA133 was also able to induce the differentiation of human mesenchymal stromal cells toward the cardiac lineage. Stem Cells 2015;33:1187–1199

[1]  Ronald A. Li,et al.  Dynamic MicroRNA Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells: Role for miR-499 , 2010, Circulation. Cardiovascular genetics.

[2]  M. Latronico,et al.  A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells , 2008, Gene Therapy.

[3]  M. McBurney,et al.  P19 embryonal carcinoma cells. , 1993, The International journal of developmental biology.

[4]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[5]  Arjun Deb,et al.  Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Marie-José Goumans,et al.  MicroRNA-1 and -499 Regulate Differentiation and Proliferation in Human-Derived Cardiomyocyte Progenitor Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[7]  S. Dimmeler,et al.  Control of cardiovascular differentiation by microRNAs , 2010, Basic Research in Cardiology.

[8]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[9]  D. Bers Calcium cycling and signaling in cardiac myocytes. , 2008, Annual review of physiology.

[10]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[11]  Joshua M Hare,et al.  Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction , 2013, Circulation.

[12]  J. P. Lopes,et al.  [Mesenchymal stem cell therapy in heart disease]. , 2013, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[13]  M. Gnecchi,et al.  Genetic therapies for cardiovascular diseases. , 2005, Trends in molecular medicine.

[14]  H. Jongsma,et al.  P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level. , 2003, Cardiovascular research.

[15]  Jing Zhang,et al.  Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.

[16]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[17]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[18]  P 19 embryonal carcinoma cells , 2007 .

[19]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[20]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[21]  K. Chien Stem cells: Lost in translation , 2004, Nature.

[22]  Zhe Han,et al.  MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Zeiher,et al.  Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. , 2007, European heart journal.

[24]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[25]  R. Yeh,et al.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. , 2008, Cell stem cell.

[26]  Roberto Bolli,et al.  Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions , 2013, Circulation research.

[27]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[28]  I. Sancho-Martinez,et al.  Reprogramming toward heart regeneration: stem cells and beyond. , 2013, Cell stem cell.

[29]  Mario Nadj,et al.  AND FUTURE DIRECTIONS , 2017 .

[30]  Alan W. Flake,et al.  Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.

[31]  M. Sampaolesi,et al.  Altered functional differentiation of mesoangioblasts in a genetic myopathy , 2013, Journal of cellular and molecular medicine.

[32]  C. Murry,et al.  Heart regeneration , 2011, Nature.

[33]  M. Ashraf,et al.  Differentiation of Bone Marrow Stromal Cells Into the Cardiac Phenotype Requires Intercellular Communication With Myocytes , 2004, Circulation.

[34]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[35]  A. Malik,et al.  Role of Ca2+ signaling in the regulation of endothelial permeability. , 2002, Vascular pharmacology.

[36]  V. Maltsev,et al.  Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels , 1994, In Vitro Cellular & Developmental Biology - Animal.

[37]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.